These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29398544)

  • 1. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
    Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
    Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors.
    Serafini M; Torre E; Aprile S; Massarotti A; Fallarini S; Pirali T
    Molecules; 2019 May; 24(10):. PubMed ID: 31096672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
    Peng YH; Liao FY; Tseng CT; Kuppusamy R; Li AS; Chen CH; Fan YS; Wang SY; Wu MH; Hsueh CC; Chang JY; Lee LC; Shih C; Shia KS; Yeh TK; Hung MS; Kuo CC; Song JS; Wu SY; Ueng SH
    J Med Chem; 2020 Feb; 63(4):1642-1659. PubMed ID: 31961685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel imidazoles as IDO1 inhibitors through microwave-assisted one-pot multicomponent reactions.
    Bai Z; Huang H; Chen J; Zhang X; Ding Y
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900165. PubMed ID: 31482583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
    Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
    J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel sulfonamide chromone-oxime derivatives as potent indoleamine 2,3-dioxygenase 1 inhibitors.
    Wang K; Song LH; Liang QL; Zhang Y; Ma XL; Wang Q; Zhang HY; Jiang CN; Wei JH; Huang RZ
    Eur J Med Chem; 2023 Jun; 254():115349. PubMed ID: 37060754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
    Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY
    J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
    Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
    Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O
    J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
    Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
    Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches.
    Zou Y; Wang Y; Wang F; Luo M; Li Y; Liu W; Huang Z; Zhang Y; Guo W; Xu Q; Lai Y
    Eur J Med Chem; 2017 Sep; 138():199-211. PubMed ID: 28667875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
    Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
    Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitors.
    Ewida MA; Ewida HA; Ahmed MS; Allam HA; ElBagary RI; George RF; Georgey HH; El-Subbagh HI
    Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100202. PubMed ID: 34313342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
    Fung SP; Wang H; Tomek P; Squire CJ; Flanagan JU; Palmer BD; Bridewell DJ; Tijono SM; Jamie JF; Ching LM
    Bioorg Med Chem; 2013 Dec; 21(24):7595-603. PubMed ID: 24262887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel High Throughput Virtual Screening Protocol to Discover New Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Xu H; Song Y; Yang Q
    Chem Pharm Bull (Tokyo); 2017; 65(8):714-717. PubMed ID: 28768924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.